<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03670862</url>
  </required_header>
  <id_info>
    <org_study_id>PROTECT-ChinaPLAGH</org_study_id>
    <nct_id>NCT03670862</nct_id>
  </id_info>
  <brief_title>Prediction Model for Recanalization Outcome Evaluation of Ischemic Stroke Using Multimodal CT</brief_title>
  <official_title>Prediction Model for Recanalization Outcome Evaluation of Ischemic Stroke Using Multimodal CT</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese PLA General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the effect of novel imaging biomarkers/ imaging patterns based on multi-model CT on
      patients selection/stratification for therapy decision support in large vessel acute ischemic
      stroke
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients Patients with cerebral ischemia sympton of anterior circulation or posterior
      circulation onset in 24 hours were included. A neurological evaluation (Modified Rankin Scale
      and NIHSS); physical examination, including measurement of weight (kg) and vital signs
      (supine systolic and diastolic blood pressure, heart rate) ; time from sympton onset to
      enrollment were recorded.

      Imaging protocols:

      CT scan protocols: No enhancement computed tomography(NECT) , computed tomography
      angiography(CTA), computed tomography perfusion(CTP)

      Contrast agent:

      CTA: Omniscan 40-50ml, 5ml/s; saline solution 50ml, 5ml/s

      CTP: Omniscan 50ml, 5ml/s; saline solution 50ml, 5ml/s

      Imaging evaluation:

      Treatment:

      Intravenous recombinant tissue plasminogen activator(rtPA), endovascular therapy and
      conventional treatment including neuro protection, ante-platelet and statin.

      Follow up:

      Five days, one month, three months and one year after imaging follow up and clinical stroke
      event and modified Rankin Scale(mRS).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Anticipated">April 9, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 9, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Patients selection/stratification</measure>
    <time_frame>Three months to 1 year</time_frame>
    <description>Finding the effect of novel imaging biomarkers/imaging patterns to provide therapy decision support in patients with large vessel acute ischemic stroke</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Therapy response</measure>
    <time_frame>Three months to 1 year</time_frame>
    <description>Finding the predictive value of novel imaging biomarkers/ imaging patterns on therapy response (recanalization therapy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90-day functional outcome</measure>
    <time_frame>Three months to 1 year</time_frame>
    <description>Finding the predictive value of novel imaging biomarkers/ imaging patterns on 90-day functional outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Final infarction volume</measure>
    <time_frame>Three months to 1 year</time_frame>
    <description>Finding the predictive value of novel imaging biomarkers/ imaging patterns on final infarction volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute posterior circulation stroke</measure>
    <time_frame>Three months to 1 year</time_frame>
    <description>Validating novel imaging biomarkers/ imaging patterns in the decision support of acute posterior circulation stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-disabling cerebrovascular event</measure>
    <time_frame>Three months to 1 year</time_frame>
    <description>Validating the acute lesion identification and recurrence prediction of multi-model CT in non-disabling cerebrovascular event</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Stroke, Acute</condition>
  <arm_group>
    <arm_group_label>stroke</arm_group_label>
    <description>Ischemic stroke patients with sympton onset in 24 hours</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CT</intervention_name>
    <description>No enhancement computed tomography , computed tomography angiography, computed tomography perfusion imaging</description>
    <arm_group_label>stroke</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Ischemic stroke patients with sympton onset in 24 hours
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cerebral ischemic sympton of anterior circulation onset in 24 hours

          -  Large vessel anterior and posterior circulation occlusion on MR or CT angiography

          -  Minor stroke (NIHSSâ‰¤3) and TIA

          -  All CT examination performed according to study protocol

          -  Signed informed consent obtained from the patient or patient's legally authorized
             representative

          -  Having complete medical history and clinical follow up

          -  Imaging data can be processed

        Exclusion Criteria:

          -  Acute intracranial hemorrhage

          -  Pre-existing medical, neurological or psychiatric disease that would confound the
             neurological, functional, or imaging evaluations

          -  Pregnancy

          -  Known allergy to iodine previously refractory to pretreatment medications

          -  Renal Failure (serum creatinine &gt; 2.0 or Glomerular Filtration Rate [GFR] &lt; 30)

          -  History of sever kidney disease as an adult, including tumor or transplant surgery, or
             family history of kidney failure

          -  Severe cardiac insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xin Lou, M.D.,Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Chinese PLA General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jinhao Lyu, M.D.</last_name>
    <phone>13391851857</phone>
    <email>lvjinhao@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chinese PLA General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100853</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinhao Lyu, BS</last_name>
      <phone>+8613391851857</phone>
      <email>lvjinhao@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>September 12, 2018</study_first_submitted>
  <study_first_submitted_qc>September 12, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 14, 2018</study_first_posted>
  <last_update_submitted>June 18, 2019</last_update_submitted>
  <last_update_submitted_qc>June 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 20, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese PLA General Hospital</investigator_affiliation>
    <investigator_full_name>Xin Lou</investigator_full_name>
    <investigator_title>Prediction model for recanalization outcome evaluation of ischemic stroke using multimodal CT</investigator_title>
  </responsible_party>
  <keyword>Ischemic stroke</keyword>
  <keyword>CTP</keyword>
  <keyword>CTA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

